Ranitidine
- Product NDC
- 71821-002
- 11-digit product format
- 718210002
- Labeler code
- 71821
- Product ID
- 71821-002_b9878674-e349-4222-8dee-b026f4f0c5b9
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Ranitidine
- Dosage form
- TABLET, FILM COATED
- Route
- ORAL
- Labeler
- VKT Pharma Private Limited
- Application
- ANDA211289
- Marketing category
- ANDA
- Marketing start
- 2019-02-18
- Marketing end
- 0000-00-00
- Substance
- RANITIDINE HYDROCHLORIDE
- Active strength
- 300 mg/1
- Pharmacologic classes
- Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2020-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 71821-002-01 | Ranitidine | 250 in 1 CONTAINER | TABLET, FILM COATED | 250 | | 1 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 71821-002 | RANITIDINE TABLET, FILM COATED [VKT PHARMA PRIVATE LIMITED] | 1 | Legacy NDC, 1 package rows | 20190220_a9f506bf-21ef-4323-9ce8-e8a7b561c496.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 71821-002-01 | 71821000201 | 250 in 1 CONTAINER | Historical |